Welcome to our dedicated page for DELIC HOLDINGS news (Ticker: DELCF), a resource for investors and traders seeking the latest updates and insights on DELIC HOLDINGS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DELIC HOLDINGS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DELIC HOLDINGS's position in the market.
Peter/PetraMD intends to acquire Ketamine Wellness Centers, enhancing its footprint in the ketamine therapy market. The transaction, valued at US$1.15 Million plus existing debt, aims to maintain patient care continuity while expanding nationally. With nearly 100,000 patients treated and experience in the field, KWC is the largest ketamine provider in the US. The acquisition signals a commitment to improving access to healthcare for veterans and others in need, according to Dr. Bryan Henry. The deal is subject to due diligence and negotiation of a definitive agreement.
Delic Holdings Corp, a leader in innovative cannabis and psychedelic treatments, announced that Dr. Markus Roggen, its President and Chief Science Officer, will be speaking at the MJBizCon on November 15, 2022 in Las Vegas. He will participate in a panel discussion titled R&D As a Business Tool: Maximizing Revenue by Focusing on The Scientific Method, emphasizing the significance of research and development in driving revenue. This event expects over 35,000 attendees and 1,400 exhibitors, showcasing networking opportunities and industry insights.
Ketamine Wellness Centers (KWC) has expanded its services by becoming one of the few U.S. ketamine therapy providers to accept Medicare coverage, enhancing accessibility for patients in eight cities: Chicago, Denver, Houston, Jacksonville, Minneapolis, Tucson, Salt Lake City, and Seattle. This initiative aims to provide affordable treatment options for mental health and pain patients, previously limited by costs. KWC, a subsidiary of Delic Holdings Corp (CSE: DELC, OTCQB: DELCF), continues to advocate for insurance coverage to facilitate access to effective therapies.
Delic Holdings Corp, through its subsidiary Ketamine Wellness Centers (KWC), has expanded its partnership with the Veterans Administration Community Care Network (VA-CCN) to provide FDA-approved esketamine nasal spray (SPRAVATO) treatments for veterans suffering from treatment-resistant depression at nine clinics across the U.S.
This initiative ensures veterans can access necessary therapies, enhancing KWC's commitment to mental health support for those who have served the nation.
Delic Holdings Corp will showcase its growth strategies at the H.C. Wainwright Annual Global Investment Conference from September 12-14, 2022. Executive Chairman Matt Stang will discuss plans for expanding the clinic footprint and adding more insurance options. The company, which operates the largest network of ketamine clinics in the U.S., aims to enhance access to treatment. A presentation will be available on-demand starting September 12, 2022, at 7 am ET.
Delic Holdings Corp has postponed the Meet Delic conference to October 14 and 15, 2023, retaining the same location in Las Vegas. Tickets from the 2022 event remain valid. The conference, known for its focus on psychedelic wellness, attracted over 2,500 attendees in 2021, showcasing talks by industry leaders and entertainment. The company anticipates that the event will further explore the benefits of psychedelics in addressing mental health issues.
Delic Holdings Corp has announced significant executive changes, appointing Matt Stang as Executive Chairman and Kevin Nicholson as CEO. Stang co-founded Delic and previously led High Times, while Nicholson is CEO of Ketamine Wellness Centers, the largest ketamine therapy provider in the U.S. Under Stang's leadership, Delic achieved total revenue exceeding USD 1.5 million last year and increased net assets by 500%, from USD 2.1 million in 2020 to USD 10 million. Delic aims to enhance treatment accessibility and provide effective healthcare solutions.
Delic Holdings Corp completed the sale of 1,240 units on July 27, 2022, raising $1,240,000. Each unit consists of a 4.0% senior secured convertible debenture and share purchase warrants. The debentures, convertible at $0.065 per share, mature in 24 months and bear 4% annual interest. Finders were compensated with cash and warrants. Proceeds will be used for expansion and corporate purposes. The securities are subject to a four-month hold period in Canada. Delic is focused on psychedelic wellness and operates multiple related businesses.
Delic Holdings Corp celebrates Dr. Markus Roggen, President and Chief Science Officer of Delic Labs, named to the Cannabis Scientist Power List for the third consecutive year. This recognition highlights his impactful work in cannabis research. Under his leadership, Delic Labs has received 56 exemptions from Health Canada for chemistry analytics on psilocybin mushrooms and is set to acquire a Dealer's License to commercialize psilocybin research. Delic aims to enhance quality control standards in psychedelic medicine.
FAQ
What is the market cap of DELIC HOLDINGS (DELCF)?
